Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$563K Buy
1,335
+3
+0.2% +$1.2K 0.17% 104
2026
Q2
$552K Sell
1,332
-105
-7% -$35.9K 0.17% 113
2026
Q1
$506K Sell
1,437
-351
-20% -$125K 0.18% 110
2025
Q4
$585K Buy
1,788
+487
+37% +$154K 0.19% 103
2025
Q3
$367K Buy
1,301
+234
+22% +$67.9K 0.15% 111
2025
Q2
$298K Buy
1,067
+214
+25% +$60.6K 0.14% 120
2025
Q1
$266K Sell
853
-515
-38% -$152K 0.13% 130
2024
Q4
$357K Buy
+1,368
New +$406K 0.18% 106

Other funds holding AMGN

Argentarii's AMGN Position: Q3 2026 in Review

Argentarii increased its Amgen (AMGN) stake by 0.23% in Q3 2026, buying an estimated $1.2K and bringing the position to 1,335 shares worth $563K. The position accounts for 0.17% of the portfolio, ranked #104.

Argentarii first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $585K in Q4 2025. 1,427 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Argentarii held 1,335 shares of Amgen worth $563K as of Q3 2026.
  • Argentarii bought 3 Amgen shares in Q3 2026, an estimated $1.2K.
  • Amgen made up 0.17% of Argentarii's portfolio in Q3 2026, its #104 holding.
  • Argentarii first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Argentarii's Amgen position peaked at $585K in Q4 2025.
  • 1,427 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.